It is important to further explore whether blockade of IL-17 sensitizes resistant oral squamous cell carcinomas to chemo-, radio- and immuno-therapy, or can it be used in the prevention of OSCC. This evidence concerns the gene IL17A and oral cavity squamous cell carcinoma.